|
Sign In to gain access to subscriptions and/or personal tools.
|
Review: Modern treatment of erectile dysfunction
Waleed Ali
Dler Besarani
The London Clinic, MITU, 20 Devonshire Place, London, W1N 2DH, UK, dler{at}doctors.org.uk
Roger Kirby
Within the last two decades, major advances have been made in the development of effective treatments for erectile dysfunction. Oral therapy is now established as the mainstay of treatment and new treatments continue to emerge following the launch of sildenafil in 1998. We review here modern treatment strategies for erectile dysfunction.
Key Words: erectile dysfunction therapy.
References
- Krane RJ, Goldstein I., Saenz de Tejada I. Impotence. N Engl J Med 1989;321: 1648-59.[Web of Science][Medline]
[Order article via Infotrieve]
- Montague DK Impotence: 1950-1983. J Urol 1984;131:526.[Web of Science][Medline]
[Order article via Infotrieve]
- Lue TF, Mueller SC, Jow YR, Hwang TI Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection. Urol Clin North Am 1989;16:799-807.[Web of Science][Medline]
[Order article via Infotrieve]
- Melman A., Gingell JC The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999;161:5-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saenz de Tejada I., Goldstein I., Azadzoi K., Krane RJ, Cohen RA Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989;320:1025-30.[Abstract]
- Feldman HA, Goldstein I., Hatzichristou DG, Krane RJ, McKinlay JB Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.[Web of Science][Medline]
[Order article via Infotrieve]
- Derby CA, Mohr BA, Goldstein I., Feldman HA, Johannes CB, McKinlay JB Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000;56:302-06.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lizza EF, Rosen RC Definition and classification of erectile dysfunction: report of the Nomenclature Committee of the International Society of Impotence Research. Int J Impot Res 1999;11:141-3.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schwarzer U., Sommer F., Klotz T., Cremer C., Engelmann U. Cycling and penile oxygen pressure: the type of saddle matters. Eur Urol 2002;41: 139-43.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sommer F., Konig D., Graft C., Schwarzer U., Bertram C., Klotz T., Engelmann U. Impotence and genital numbness in cyclists. Int J Sports Med 2001;22:410-13.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Curry A. Holey bike seats! You won't believe what cycling could do to you. US News World Rep 2000;129:53.[Medline]
[Order article via Infotrieve]
- Masters WH, Johnson V. Human sexual inadequacy. Boston, Little, Brown & Co., 1970.
- Lue TF, Broderick G. Evaluation and nonsurgical management of erectile dysfunction and priapism. In Walsh PC, Retik AB, Vaughan ED, Wein AJ eds. Campbell's Urology. 7th edn. Vol. 2. Chapter 39. Philadelphia: Saunders.1998:1181-214.
- Morales A., Surridge DH, Marshall PG, Fenemore J. Nonhormonal pharmacological treatment of organic impotence. J Urol 1982;128:45-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Reid K., Surridge DH, Morales A. et al. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 1987;2:421-3.[Web of Science][Medline]
[Order article via Infotrieve]
- Goldstein I., Lue TF, Padma-Nathan H., Rosen RC, Steers WD, Wicker PA Oral sildenafil in the treatment of erectile dysfunction. 1998. J Urol 2002;167:1197-203.[Web of Science][Medline]
[Order article via Infotrieve]
- Goldstein I., Lue TF, Padma-Nathan H., Rosen RC, Steers WD, Wicker PA Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-404.[Abstract/Free Full Text]
- Klotz T., Sachse R., Heidrich A. et al. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study. World J Urol 2001;19:32-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saenz de Tejada I., Angulo J., Cuevas P. et al. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE-5 inhibitor vardenafil. Int J Impot Res 2001;13:282-90.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Porst H., Rosen R., Padma-Nathan H. et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res 2001;13:192-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Eardley I., Cartledge J. Tadalafil (Cialis) for men with erectile dysfunction. Int J Clin Pract 2002;56:300-04.[Web of Science][Medline]
[Order article via Infotrieve]
- Porst H. IC351 (tadalafil, Cialis): update on clinical experience. Int J Impot Res 2002;14(suppl 1):S57-S64.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Heaton JP, Dean J., Sleep DJ Sequential administration enhances the effect of apomorphine SL in men with erectile dysfunction. Int J Impot Res 2002;14:61-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mirone VG, Stief CG Efficacy of apomorphine SL in erectile dysfunction. BJU Int 2001;88(suppl 3):25-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Dula E., Bukofzer S., Perdok R., George M. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol 2001;39:558-63.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Bukofzer S., Livesey N. Safety and tolerability of apomorphine SL (Uprima). Int J Impot Res 2001;139(suppl 3):S40-S44.
- Morales A., Johnston B., Heaton JW, Clark A. Oral androgens in the treatment of hypogonadal impotent men. J Urol 1994;152:1115-18.[Web of Science][Medline]
[Order article via Infotrieve]
- Derouet H., Caspari D., Rohde V., Rommel G., Ziegler M. Treatment of erectile dysfunction with external vacuum devices. Andrologia 1999;31 (suppl 1):89-94.[Web of Science][Medline]
[Order article via Infotrieve]
- Kiely EA, Ignotus P., Williams G. Penile function following intracavernosal injection of vasoactive agents or saline. Br J Urol 1987;59:473-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Gasser TC, Roach RM, Larsen EH, Madsen PO, Bruskewitz RC Intracavernous self-injection with phentolamine and papaverine for the treatment of impotence. J Urol 1987;137:678-80.[Web of Science][Medline]
[Order article via Infotrieve]
- Virag R. Intracavernous injection of papaverine for erectile failure. 1982. J Urol 2002;167:1196.
- Tsai YS, Lin JS, Lin YM Safety and efficacy of alprostadil sterile powder (S. Po., CAVERJECT) in diabetic patients with erectile dysfunction. Eur Urol 2000;38:177-83.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Brock G., Tu LM, Linet OI Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urology 2001; 57:536-41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Wolfson B., Pickett S., Scott NE, DeKernion JB, Rajfer J. Intraurethral prostaglandin E-2 cream: a possible alternative treatment for erectile dysfunction. Urology 1993;42:73-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Goldstein I. Arterial revascularization procedures. Semin Urol 1986; 4:252-8.[Medline]
[Order article via Infotrieve]
- Donatucci CF, Lue TF Venous surgery: Are we kidding ourselves? In: Lue TF, ed. World book of impotence. London: Smith-Gordon and Co, 1992;221-7.
- Carson CC, Robertson CN Late hematogenous infection of penile prostheses. J Urol 1988;139:50-2.[Web of Science][Medline]
[Order article via Infotrieve]
- Carson CC, III. Antimicrobial agents in urinary tract infections in patients with spinal cord injury. Urol Clin North Am 1993;20:443-52.[Web of Science][Medline]
[Order article via Infotrieve]
- Montague DK, Angermeier KW Penile prosthesis implantation. Urol Clin North Am 2001;28:355-61.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lewis RW Long-term results of penile prosthetic implants.Urol Clin North Am 1995;22:847-56.[Web of Science][Medline]
[Order article via Infotrieve]
- Furlow WL, Goldwasser B., Gundian JC Implantation of model AMS 700 penile prosthesis: long-term results. J Urol 1988;139:741-2.[Web of Science][Medline]
[Order article via Infotrieve]
The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 4,
255-261 (2002)
DOI: 10.1177/14746514020020040301

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Jamieson, J. Chalmers, C. Duncan, R. J Prescott, and I. W Campbell
Erectile dysfunction in type 1 diabetic males
The British Journal of Diabetes & Vascular Disease,
September 1, 2008;
8(5):
232 - 234.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hood and M. Kirby
Review: PDE-5 inhibitors -- a summary
The British Journal of Diabetes & Vascular Disease,
November 1, 2004;
4(6):
383 - 386.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hood and M. Kirby
Review: Risk factor assessment of erectile dysfunction
The British Journal of Diabetes & Vascular Disease,
May 1, 2004;
4(3):
157 - 161.
[Abstract]
[PDF]
|
 |
|
|
|